TaiMed leverages strong scientific expertise and global partnerships to bring novel treatments to market. Headquartered in Taipei, it aims to address unmet medical needs while expanding its pipeline into other therapeutic areas, positioning itself as a key player in the global biotechnology industry. In addition, the company provides contract development and manufacturing organization (CDMO) services, supporting biopharmaceutical partners from early-stage development to commercial production, with a mission to address unmet medical needs worldwide.